The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.
Emily Burke
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Haluk Tezcan
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Margarita Lopatin
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Kim Michelle Clark-Langone
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Mark Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Amy Pratt Sing
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health